期刊文献+

氟伐他汀调脂疗效及对血管内皮功能保护作用的观察 被引量:2

Efficacy of Fluvastatin in Treating Hyperlipidemia and Improving Endothelial Function in Patients with Hyperlipidemia
下载PDF
导出
摘要 目的 观察氟伐他汀 2 0mg/d对原发性高胆固醇血症患者血脂的影响及对血管内皮功能保护作用。 方法  6 7例初诊未曾应用药物治疗的原发性高胆固醇血症患者每晚服用氟伐他汀 2 0mg/d ,于用药前及用药 4周检测血脂、血液生化 ,并应用放免法测定血浆内皮素 (endothelins,ET)及酶法测定一氧化氮 (nitrogenmonoxide,NO)水平。结果 用药 4周后 ,血清总胆固醇 (totalcholestero ,TC)水平下降 1 8.1 %。低密度脂蛋白胆固醇 (lowdensitylipoproteincholestero,LDL C)下降 2 4 .9%,高密度脂蛋白胆固醇 (highdensitylipoproteincholestero ,HDL C)升高7.5 %,血清甘油三酯 (triglycerides,TG)下降 1 1 .1 %。这四项指标均有统计学意义 (P =0 .0 38,P =0 .0 0 1 ,P =0 .0 2 5 ,P =0 .0 1 )。用药 4周后 ,ET有所下降 ,NO及NO/ET明显升高 (P =0 .0 96 ,P =0 .0 4 2 ,P =0 .0 2 5 )。治疗前后血清生化指标无显著变化。结论 氟伐他汀有效治疗高脂血症的同时 ,具有良好的内皮保护作用。 Objective To investigate the efficacy and safety of Fluvastatin in improving endothelial function in patients with hyperlipidemia.Methods Fluvastatin 20 mg/d was used in 67 patients with hypercholesterolemia.Before and after 4 weeks' treatment,serum lipids,lipoproteins,other biochemistry data,plasma endothelin (ET) and nitrogen monoxide(NO) were examined.Results After 4 weeks' treatment,serum level of total cholesterol (TC),triglyceride (TG),low density lipoprotein cholesterol (LDL C) significantly decreased 18.1%?11.1%?24.9% respectively( P =0.038, P = 0.001 , P =0.025, P =0.01),and high density lipoprotein cholesterol (HDL C) increased 7.5% significantly ( P = 0.01 ).NO and the ratio of NO/ET increased significantly ( P =0.096, P =0.042, P =0.025).Other indices in biochemistry did not change significantly.Conclusion Fluvastatin with the dose of 20 mg/d is not only effective and safe,but also improves vascular endothelial function in treating patients with hyperlipidemia.
出处 《同济大学学报(医学版)》 CAS 2004年第4期322-324,共3页 Journal of Tongji University(Medical Science)
关键词 氟伐他汀 高脂血症 内皮功能 Fluvastatin hyperlipidemia vascular endothelial function
  • 相关文献

参考文献7

  • 1李健斋.血脂测定技术及其标准化的建议[J].中华心血管病杂志,1997,25(3):172-173.
  • 2Riegger G, Abletshauser C, Ludwig M, et al. The effect of fluvastatin on cardiac events in patients with symptomatic coronary artery disease during one year of treatment[J]. Atherosclerosis, 1999,144(1): 263 - 70.
  • 3Stefan B, Conrad P, Michael W, et al. Fluvastatin lipidlowering effect in routine practice conditions (FLIRT)results of a drug surveillance study on behalf of the fluvastatin investigators [J]. Clin Drug Invest, 1997, 14 (2):146-153.
  • 4Serruys PW, Foley DP,Jackson G, et al.A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial [J]. Eur Heart J,
  • 5Branchi A, Fiorenza AM, Rovellini A, et al. Lowering effects of four different statins on serum triglyceride level[J]. Eur J Clin Pharmacol, 1999,55(7) :499 - 502.
  • 6Ballantyne CM, Herd JA, Ferlic LL, et al. Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy[J]. Circulation, 1999, 99(6):736 - 743.
  • 7Taddei S,Virdis A,Ghiadoni L,et al. Menopause is associated with endothelial dysfunction in women [J]. Hypertension, 1996,28(4): 576 - 582.

共引文献21

同被引文献20

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部